Search research articles
Contact Us
Filters
Showing results (81-90 of 86) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 86 results.
The Journal of Clinical Endocrinology and Metabolism
|
September 24, 1998
Octreotide as primary therapy for acromegaly
C B Newman, S Melmed, A George, et al.
Journal of Endocrinological Investigation
|
April 2, 2004
Diagnosis and treatment of acromegaly complications
A Giustina, F F Casanueva, F Cavagnini, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 13, 2003
Diagnosis and complications of Cushing's syndrome: a consensus statement
G Arnaldi, A Angeli, A B Atkinson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 17, 2008
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement
B M K Biller, A B Grossman, P M Stewart, et al.
Lancet (London, England)
|
December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
A J van der Lely, R K Hutson, P J Trainer, et al.
The New England Journal of Medicine
|
April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
P J Trainer, W M Drake, L Katznelson, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 86) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 86 results.
The Journal of Clinical Endocrinology and Metabolism
|
September 24, 1998
Octreotide as primary therapy for acromegaly
C B Newman, S Melmed, A George, et al.
Journal of Endocrinological Investigation
|
April 2, 2004
Diagnosis and treatment of acromegaly complications
A Giustina, F F Casanueva, F Cavagnini, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 13, 2003
Diagnosis and complications of Cushing's syndrome: a consensus statement
G Arnaldi, A Angeli, A B Atkinson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 17, 2008
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement
B M K Biller, A B Grossman, P M Stewart, et al.
Lancet (London, England)
|
December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
A J van der Lely, R K Hutson, P J Trainer, et al.
The New England Journal of Medicine
|
April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
P J Trainer, W M Drake, L Katznelson, et al.
Page
of 9